📰 Human Use News
Page 72 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
May 5, 2023
RIYADH: The Saudi Food and Drug Authority (SFDA), in cooperation with the International Council for Harmonization of Technical Requirements of Pharmaceuticals for Human Use (ICH), organized regulatory training on quality guidelines, providing assessors with in-depth knowledge and experience in the fields of chemistry, manufacturing and control. The four-week training program,
May 5, 2023
The vital recommendation ensures marketing authorisation for treating the hepatitis delta virus - News - PharmaTimes
May 4, 2023
FDA approval of GSK’s respiratory syncytial vaccine Arexvy covers adults age 60 and older—an age group at particular risk of developing severe complications from infection. GSK plans to launch Arexvy in time for the 2023/2024 RSV season.
May 4, 2023
-- If Granted by the European Commission, Hepcludex will Become the Only Approved Treatment for HDV in the EU -- ... | May 4, 2023
May 4, 2023
/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization...
May 4, 2023
If Granted by the European Commission, Hepcludex will Become the Only Approved Treatment for HDV in the EU -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal
May 4, 2023
/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative temperature-controlled supply chain...
May 4, 2023
Protalix BioTherapeutics Reports First Quarter 2023 Financial and Business Results - read this article along with other careers information, tips and advice on BioSpace
May 3, 2023
The purpose of this guidance is to offer a systematic approach to quality risk management for better, more informed, and timely decisions. It serves as a foundation that is independent of, yet supports, other ICH Quality documents and complements existing quality practices, requirements, stand
May 3, 2023
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time The approval is based on data from the positive pivotal AReSVi-006 phase III... | May 3, 2023